MaaT Pharma SA (EPA:MAAT)
France · Delayed Price · Currency is EUR 3.190
+0.070 (2.24%)
Aug 21, 2026, 5:35 PM CET
MaaT Pharma Financials Overview
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 4.52 | 4.52 | 3.22 | 2.23 | 1.43 | 0.97 |
Revenue Growth | 15.35% | 40.67% | 44.34% | 55.80% | 47.12% | - |
Gross Profit Gross Profit Growth | 2.8 | 2.8 | 1.6 | 1.35 | 0.79 | 0.64 |
Operating Income Operating Income Growth | -29.73 | -29.73 | -28.43 | -19.94 | -13.56 | -8.89 |
Net Income Net Income Growth | -31.06 | -31.06 | -28.9 | -19.72 | -13.71 | -9.02 |
Earnings Per Share EPS Growth | -1.95 | -1.95 | -2.21 | -1.73 | -1.39 | -3.72 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Export and Intra-Community Export and Intra-Community Growth | 0.07 | 0.07 | - | - | - | - |
France France Growth | 4.46 | 4.46 | 3.22 | 2.23 | 1.43 | 0.97 |
Total Total Growth | 4.52 | 4.52 | 3.22 | 2.23 | 1.43 | 0.97 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 24.87 | 24.87 | 20.15 | 24.28 | 35.31 | 43.31 |
Total Debt Total Debt Growth | 17.44 | 17.44 | 15.96 | 14.08 | 11.36 | 5.81 |
Net Cash (Debt) Net Cash Growth | 7.43 | 7.43 | 4.2 | 10.21 | 23.95 | 37.5 |
Net Cash Growth | 1073.30% | 76.96% | -58.87% | -57.39% | -36.13% | 171.00% |
Net Cash Per Share Net Cash Per Share Growth | 0.47 | 0.47 | 0.32 | 0.90 | 2.42 | 15.45 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -15.72 | -15.72 | -22.04 | -18.67 | -12.61 | -7.93 |
Capital Expenditures CapEx Growth | -0.61 | -0.61 | -0.75 | -1.09 | -0.66 | -0.24 |
Free Cash Flow Free Cash Flow Growth | -16.33 | -16.33 | -22.79 | -19.76 | -13.27 | -8.17 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 61.80% | 61.80% | 49.81% | 60.59% | 55.11% | 66.05% |
Operating Margin | -657.14% | -657.14% | -883.95% | -895.11% | -947.97% | -914.92% |
Pretax Margin | -686.58% | -686.58% | -898.76% | -884.96% | -958.95% | -927.88% |
Profit Margin | -686.58% | -686.58% | -898.76% | -884.96% | -958.95% | -927.88% |
FCF Margin | -360.88% | -360.88% | -708.77% | -887.03% | -927.76% | -840.23% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 23, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PS Ratio | 13.29 | 17.12 | 34.39 | 36.35 | 55.35 | 135.75 |